Brick & Kyle Associates’s Bristol-Myers Squibb BMY Stock Holding History

Brick & Kyle Associates’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.26M	Hold	20,796	–	–	0.42%	44
2026 Q1	$1.26M	Buy	+20,796	New	+$1.21M	0.42%	44
2019 Q1	–	Sell	-37,957	Closed	-$1.97M	–	67
2018 Q4	$1.97M	Buy	+37,957	New	+$2.04M	1.89%	19
2018 Q2	$2.23M	Sell	40,369 -12,692	-24%	-$685K	1.75%	22
2018 Q1	$3.36M	Sell	53,061 -592	-1%	-$38.1K	2.71%	8
2017 Q4	$3.29M	Sell	53,653 -268	-0.5%	-$16.8K	2.67%	10
2017 Q3	$3.44M	Buy	53,921 +62	+0.1%	+$3.62K	2.78%	8
2017 Q2	$3M	Sell	53,859 -3,316	-6%	-$180K	2.58%	13
2017 Q1	$3.11M	Sell	57,175 -4,028	-7%	-$221K	2.41%	9
2016 Q4	$3.58M	Buy	61,203 +2,029	+3%	+$111K	2.87%	2
2016 Q3	$3.19M	Buy	59,174 +741	+1%	+$47.6K	2.57%	4
2016 Q2	$4.3M	Buy	58,433 +1,020	+2%	+$72.1K	3.52%	1
2016 Q1	$3.67M	Buy	57,413 +146	+0.3%	+$9.21K	3.18%	2
2015 Q4	$3.94M	Buy	57,267 +5,083	+10%	+$336K	3.47%	2
2015 Q3	$3.09M	Buy	52,184 +1,978	+4%	+$125K	2.9%	3
2015 Q2	$3.34M	Buy	50,206 +1,798	+4%	+$118K	2.8%	4
2015 Q1	$3.12M	Buy	48,408 +2,240	+5%	+$140K	2.67%	5
2014 Q4	$2.73M	Buy	+46,168	New	+$2.6M	2.35%	7

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Brick & Kyle Associates's BMY Position: Q2 2026 in Review

Brick & Kyle Associates held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 20,796 shares worth $1.26M. The position accounts for 0.42% of the portfolio, ranked #44.

Brick & Kyle Associates first reported a position in BMY in Q4 2014 and has held it in 18 quarters since. The position peaked at $4.3M in Q2 2016. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Brick & Kyle Associates held 20,796 shares of Bristol-Myers Squibb worth $1.26M as of Q2 2026.
Brick & Kyle Associates left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.42% of Brick & Kyle Associates's portfolio in Q2 2026, its #44 holding.
Brick & Kyle Associates first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 18 quarters since.
Brick & Kyle Associates's Bristol-Myers Squibb position peaked at $4.3M in Q2 2016.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Brick & Kyle Associates's 13F filing for Q2 2026, filed 6 Aug 2026.